A convenient luminescence assay of ferroportin internalization to study its interaction with hepcidin

FEBS Journal

Volumn 280, Issue 8, 2013, Pages 1773-1781

  Song, Ge ^a,b   Jiang, Qian ^a   Xu, Ting ^a   Liu, Ya Li ^a,b   Xu, Zeng Guang ^b   Guo, Zhan Yun ^a  

^a TONGJI UNIVERSITY   (China)

^b TONGJI UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

ferroportin; hepcidin; interaction; internalization; luminescence assay

Indexed keywords

ENHANCED GREEN FLUORESCENT PROTEIN; FERROPORTIN; HEPCIDIN; LUCIFERASE; NANOLUCIFERASE; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; ASSAY; CARBOXY TERMINAL SEQUENCE; CONTROLLED STUDY; EMBRYO; FEMALE; FLUORESCENCE; GENE EXPRESSION SYSTEM; HUMAN; HUMAN CELL; INTERNALIZATION; LUMINESCENCE; LUMINESCENCE ASSAY; MUTANT; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROTEIN INTERACTION; QUALITATIVE ANALYSIS; QUANTITATIVE ANALYSIS; WILD TYPE;

ANTIMICROBIAL CATIONIC PEPTIDES; CATION TRANSPORT PROTEINS; CELL MEMBRANE PERMEABILITY; HEK293 CELLS; HUMANS; LUMINESCENT MEASUREMENTS; TRANSFECTION;

EID: 84876285416     PISSN: 1742464X     EISSN: 17424658     Source Type: Journal    
DOI: 10.1111/febs.12192     Document Type: Article

References (23)

1. Krause A, Neitz S, Mägert HJ, Schulz A, Forssmann WG, Schulz-Knappe P, &, Adermann K, (2000) LEAP-1, a novel highly disulfide-bonded human peptide, exhibits antimicrobial activity. FEBS Lett 480, 147-150.
2. Park CH, Valore EV, Waring AJ, &, Ganz T, (2001) Hepcidin, a urinary antimicrobial peptide synthesized in the liver. J Biol Chem 276, 7806-1810.
3. Pigeon C, Ilyin G, Courselaud B, Leroyer P, Turlin B, Brissot P, &, Loréal O, (2001) A new mouse liver-specific gene, encoding a protein homologous to human antimicrobial peptide hepcidin, is overexpressed during iron overload. J Biol Chem 276, 7811-7819.
4. Nemeth E, Tuttle MS, Powelson J, Vaughn MB, Donovan A, Ward DM, Ganz T, &, Kaplan J, (2004) Hepcidin regulates cellular iron efflux by binding to ferroportin and inducing its internalization. Science 306, 2090-2093.
5. Ganz T, &, Nemeth E, (2011) Hepcidin and disorders of iron metabolism. Annu Rev Med 62, 347-360.
6. Hentze MW, Muckenthaler MU, Galy B, &, Camaschella C, (2010) Two to tango: regulation of mammalian iron metabolism. Cell 142, 24-38.
7. Donovan A, Brownlie A, Zhou Y, Shepard J, Pratt SJ, Moynihan J, Paw BH, Drejer A, Barut B, Zapata A, et al,. (2000) Positional cloning of zebrafish ferroportin1 identifies a conserved vertebrate iron exporter. Nature 403, 776-781.
8. Abboud S, &, Haile DJ, (2000) A novel mammalian iron-regulated protein involved in intracellular iron metabolism. J Biol Chem 275, 19906-19912.
9. McKie AT, Marciani P, Rolfs A, Brennan K, Wehr K, Barrow D, Miret S, Bomford A, Peters TJ, Farzaneh F, et al,. (2000) A novel duodenal iron-regulated transporter, IREG1, implicated in the basolateral transfer of iron to the circulation. Mol Cell 5, 299-309.
10. Brissot P, Bardou-Jacquet E, Jouanolle AM, &, Loréal O, (2011) Iron disorders of genetic origin: a changing world. Trends Mol Med 17, 707-713.
11. Rice AE, Mendez MJ, Hokanson CA, Rees DC, &, Björkman PJ, (2009) Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter. J Mol Biol 386, 717-732.
12. De Domenico I, Nemeth E, Nelson JM, Phillips JD, Ajioka RS, Kay MS, Kushner JP, Ganz T, Ward DM, &, Kaplan J, (2008) The hepcidin-binding site on ferroportin is evolutionarily conserved. Cell Metab 8, 146-156.
13. Preza GC, Ruchala P, Pinon R, Ramos E, Qiao B, Peralta MA, Sharma S, Waring A, Ganz T, &, Nemeth E, (2011) Minihepcidins are rationally designed small peptides that mimic hepcidin activity in mice and may be useful for the treatment of iron overload. J Clin Invest 121, 4880-4888.
14. Mayr R, Janecke AR, Schranz M, Griffiths WJ, Vogel W, Pietrangelo A, &, Zoller H, (2010) Ferroportin disease: a systematic meta-analysis of clinical and molecular findings. J Hepatol 53, 941-949.
15. De Domenico I, Ward DM, Nemeth E, Vaughn MB, Musci G, Ganz T, &, Kaplan J, (2005) The molecular basis of ferroportin-linked hemochromatosis. Proc Natl Acad Sci USA 102, 8955-8960.
16. De Domenico I, Ward DM, Musci G, &, Kaplan J, (2007) Evidence for the multimeric structure of ferroportin. Blood 109, 2205-2209.
17. Schimanski LM, Drakesmith H, Merryweather-Clarke AT, Viprakasit V, Edwards JP, Sweetland E, Bastin JM, Cowley D, Chinthammitr Y, Robson KJH, et al,. (2005) In vitro functional analysis of human ferroportin (FPN) and hemochromatosis-associated FPN mutations. Blood 105, 4096-4102.
18. Gonçalves AS, Muzeau F, Blaybel R, Hetet G, Driss F, Delaby C, Canonne-Hergaux F, &, Beaumont C, (2006) Wild type and mutant ferroportins do not form oligomers in transfected cells. Biochem J 396, 265-275.
19. Clark RJ, Tan CC, Preza GC, Nemeth E, Ganz T, &, Craik DJ, (2011) Understanding the structure/activity relationships of the iron regulatory peptide hepcidin. Chem Biol 18, 336-343.
20. Ross SL, Tran L, Winters A, Lee KJ, Plewa C, Foltz I, King C, Miranda LP, Allen J, Beckman H, et al,. (2012) Molecular mechanism of hepcidin-mediated ferroportin internalization requires ferroportin lysines, not tyrosines or JAK-STAT. Cell Metab 15, 905-917.
21. Hall MP, Unch J, Binkowski BF, Valley MP, Butler BL, Wood MG, Otto P, Zimmerman K, Vidugiris G, Machleidt T, et al,. (2012) Engineered luciferase reporter from a deep sea shrimp utilizing a novel imidazopyrazinone substrate. ACS Chem Biol 7, 1848-1857.
22. Luo X, Jiang Q, Song G, Liu YL, Xu ZG, &, Guo ZY, (2012) Efficient oxidative folding and site-specific labeling of human hepcidin to study its interaction with receptor ferroportin. FEBS J 279, 3166-3175.
23. Zhang WJ, Luo X, Liu YL, Shao XX, Wade JD, Bathgate RA, &, Guo ZY, (2012) Site-specific DOTA/europium-labeling of recombinant human relaxin-3 for receptor-ligand interaction studies. Amino Acids 43, 983-992.